Clinical Trial Implications for Study Participants Accessing Medical Assistance in Dying | Zendy

Blair Henry | Zendy; Sally Bean | Zendy; Y.J. Ko | Zendy; Debbie Selby | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Trial Implications for Study Participants Accessing Medical Assistance in Dying

Author(s) -

Blair Henry,

Sally Bean,

Y.J. Ko,

Debbie Selby

Publication year - 2019

Publication title -

current oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.053

H-Index - 51

eISSN - 1718-7729

pISSN - 1198-0052

DOI - 10.3747/co.26.4609

Subject(s) - legalization , medicine , alternative medicine , end of life care , family medicine , palliative care , medical care , gerontology , clinical trial , nursing , psychiatry , pathology

Further prospective data collection and a biostatistical analysis are needed before any conclusions can be drawn about the potential impact of maid on cancer trial results. A research effort of this kind is particularly important given that federal reporting requirements do not track this metric, and we are unaware of any uniform clinical trial approach to collecting such data.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research